Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy

Folia Histochemica et Cytobiologica

Volumn 47, Issue 2, 2009, Pages 207-213

  Naumnik, Wojciech ^a   Niklińska, Wiesława ^a   Ossolińska, Maria ^a   Chyczewska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cathepsin K; Chemotherapy; Cystatin C; Lung cancer; Non small cell lung cancer; NSCLC

Indexed keywords

CATHEPSIN K; CISPLATIN; CREATININE; CYSTATIN C; GEMCITABINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL TIME;

EID: 73549112017     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0024-0     Document Type: Article

References (27)

1. Bühling F, Röcken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Brömme D, Welte T. Pivotal role of cathepsin K in lung fibrosis. Am J Pathol. 2004;164:2203-2216.
2. Bühling F, Waldburg N, Gerber A, Häckel C, Krüger S, Reinhold D, Brömme D, Weber E, Ansorge S, Welte T. Cathepsin K expression in human lung. Adv Exp Med Biol. 2000;477:281-286.
3. Bühling F, Reisenauer A, Gerber A, Krüger S, Weber E, Brömme D, Roessner A, Ansorge S, Welte T, Röcken C. Cathepsin K; a marker of macrophage differentiation? J Pathol. 2001;195:375-382.
4. Bühling F, Gerber A, Häckel C, Krüger S, Köhnlein T, Brömme D, Reinhold D, Ansorge S, Welte T. Expression of cathepsin K in lung epithelial cells. Am J Respir Cell Mol Biol. 1999;20:612-619.
5. Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, Kokubo T, Inaoka T, Sloane J, Evans DB, Gallagher JA. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 1997; 57:5386-5390.
6. Brubaker KD, Vessella RL, True LD, Thomas R, Corey E. Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res. 2003;18:222-230.
7. Rapa I, Volante M, Cappia S, Rosas R, Scagliotti GV, Papotti M. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth. Am J Clin Pathol. 2006;125:847-854.
8. Tumminello FM, Flandina C, Crescimanno M, Leto G. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications. Biomed Pharmacother. 2008;62:130-135.
9. Nakai K, Kikuchi M, Fujimoto K, Kaneko Y, Omori S, Nakai K, Suwabe A. Serum levels of cystatin C in patients with malignancy. Clin Exp Nephrol. 2008;12:132-139.
10. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases,is elevated in asthmatic patients. Clin Chim Acta. 2000;300:83-95.
11. Kos J, Stabuc B, Cimerman N, Brünner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem. 1998;44:2556-2557.
12. Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers. 2008;23:161-168.
13. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res. 2008;14:5357-5367.
14. Strojan P, Oblak I, Svetic B, Smid L, Kos J. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis. Br J Cancer. 2004;90:1961-1968.
15. Finney H, Williams AH, Price CP. Serum cystatin C in patients with myeloma. Clin Chim Acta. 2001;309:1-6.
16. Cole T, Dickson P, Esnard F, Averill S, Risbridger G, Gauthier F, Schreiber G. The cDNA structure and expression analysis of the genes for the cysteine proteinase inhibitor cystatin C and for b2-microglobulin in rat brain. Eur J Biochem. 1989;186:35-42.
17. Werle B, Schanzenbächer U, Lah TT, Ebert E, Jülke B, Ebert W, Fiehn W, Kayser K, Spiess E, Abrahamson M, Kos J. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis. Oncol Rep. 2006;16:647-655.
18. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, Suzumori K. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol. 2004;92:881-886.
19. Dreilich M, Wagenius G, Bergström S, Brattström D, Larsson A, Hesselius P, Bergqvist M. The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma. Med Oncol. 2005;22:29-38.
20. Kos J and Lah TT. Cysteine proteinases and their endogenous inhibitors: Target proteins for prognosis, diagnosis and therapy in cancer. Oncol Rep. 1998;5:1349-1361.
21. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, Skrk J. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2000;6:1052-1062.
22. Strojan P, Oblak I, Svetic B, Smid L and Kos J. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis. Br J Cancer 2004;90:1961-1968.
23. Kos J, Krašovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brünner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res. 2000;6:505-511.
24. Huh CG, Hakansson K, Nathanson CM, Thorgeirsson UP, Jonsson N, Grubb A, Abrahamson M, Karlsson S. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol. 1999;52:332-340.
25. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jäättelä M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol. 2001;153:999-1010.
26. Chapman HA, Riese JR and Shi GP. Emerging roles for cysteine proteinases in human biology. Annu Rev Physiol. 1997;59:63-88.
27. Kos J, Sekirnik A, Kopitar G, Cimerman N, Kayser K, Stremmer A, Fiehn W, Werle B. Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br J Cancer. 2001;85:1193-1200.